plasma concentrations of perphenazine ( ppz ) ( trilafon ) and perphenazinesulphoxide ( ppzso ) were estimated during a 2-week period in 16 patients receiving peroral ppz treatment for various psychotic disorders .
C0031184
ppz
C0033975
psychotic disorders